Table 2 |
|||||||
|
Use of anti-malarial drugs during pregnancy |
|||||||
| District |
Pangani |
Tanga |
Korogwe |
TOTAL |
|||
|
|
|||||||
| Facility level |
District Hospital |
Dispensary |
District Hospital |
Health Centre |
District Hospital |
Dispensary |
|
|
|
|||||||
| Respondents per facility |
17 |
13 |
32 |
28 |
19 |
10 |
119 |
| Any anti-malarials taken during this pregnancy |
|||||||
| As treatment, n (%) |
3 (17.7) |
2 (15.4) |
8 (25.0) |
5 (17.9) |
4 (21.1) |
1 (10.0) |
23 (19.3) |
| As prevention, n (%) |
12 (70.6) |
9 (69.2) |
12 (37.5) |
14 (50.0) |
11 (57.9) |
9 (90.0) |
67 (56.3) |
| Heard of IPTp, n (%) |
14 (82.4) |
11 (84.6) |
19 (59.4) |
24 (85.7) |
18 (94.7) |
10 (100) |
96 (80.7) |
| Received any doses IPTp† |
|||||||
| Overall, n (%) |
9 (52.9) |
7 (53.9) |
11 (34.4) |
15 (53.6) |
14 (73.7) |
9 (90.0%) |
65 (54.6) |
| Uptake among those ≥ 5 months gestation* |
64.3% |
77.8% |
40.0% |
62.5% |
100% |
100% |
67.0% |
| Received ≥ 2 doses IPTp† |
|||||||
| Overall, n (%) |
7 (41.2) |
5 (38.5) |
4 (12.5) |
5 (17.9) |
6 (31.6) |
4 (40.0) |
31 (26.1) |
| Uptake among those ≥ 7 months gestation** |
87.5% |
75.0% |
16.7% |
30.8% |
85.7% |
66.7% |
48.2% |
|
|
|||||||
|
†Respondents who had not heard of IPTp were not asked about doses received *Denominator is number of respondents who were 5 months gestation or later **Denominator is number of respondents who were 7 months gestation or later |
|||||||
|
Anders et al. Malaria Journal 2008 7:79 doi:10.1186/1475-2875-7-79 |
|||||||
